These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18315546)

  • 21. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.
    Batlle J; Pérez-Rodríguez A; Corrales I; López-Fernández MF; Rodríguez-Trillo Á; Lourés E; Cid AR; Bonanad S; Cabrera N; Moret A; Parra R; Mingot-Castellano ME; Balda I; Altisent C; Pérez-Montes R; Fisac RM; Iruín G; Herrero S; Soto I; de Rueda B; Jiménez-Yuste V; Alonso N; Vilariño D; Arija O; Campos R; Paloma MJ; Bermejo N; Toll T; Mateo J; Arribalzaga K; Marco P; Palomo Á; Sarmiento L; Iñigo B; Nieto Mdel M; Vidal R; Martínez MP; Aguinaco R; César JM; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Cornudella R; Aguilar C; Borràs N; Vidal F
    Thromb Haemost; 2016 Jan; 115(1):40-50. PubMed ID: 26245874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand disease mutation spectrum and associated mutation mechanisms.
    de Jong A; Eikenboom J
    Thromb Res; 2017 Nov; 159():65-75. PubMed ID: 28987708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization.
    Szántó T; Schlammadinger A; Salles I; Pareyn I; Vauterin S; Hársfalvi J; Vanden Bulcke AM; Deckmyn H; Vanhoorelbeke K
    Thromb Haemost; 2007 Jul; 98(1):251-4. PubMed ID: 17598021
    [No Abstract]   [Full Text] [Related]  

  • 24. von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
    Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
    J Thromb Haemost; 2006 Sep; 4(9):2088-90. PubMed ID: 16961623
    [No Abstract]   [Full Text] [Related]  

  • 25. von Willebrand disease: pathogenesis, classification, and management.
    Murray EW; Lillicrap D
    Transfus Med Rev; 1996 Apr; 10(2):93-110. PubMed ID: 8721967
    [No Abstract]   [Full Text] [Related]  

  • 26. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification.
    Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC
    Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353
    [No Abstract]   [Full Text] [Related]  

  • 27. Allelic frequencies of three VNTRs in intron 40 of the human von Willebrand factor gene in types 1, 2, and 3 von Willebrand disease patients and controls of a Brazilian population.
    Mazzini J; Hackel C; Annichino-Bizzacchi JM
    Thromb Res; 2000 Dec; 100(6):489-94. PubMed ID: 11152928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Von Willebrand disease in the Netherlands: the WiN study].
    Sanders YV; de Wee EM; Meijer K; Eikenboom J; van der Bom JG; Fijnvandraat CJ; Laros-van Gorkom BA; Cnossen MH; Mauser-Bunschoten EP; Leebeek FW
    Ned Tijdschr Geneeskd; 2014; 158():A6518. PubMed ID: 24800796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease.
    Piao YC; Lavergne JM; Boyer-Neumann C; Schandelong A; Alessi MC; Meyer D
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):787-9. PubMed ID: 8292729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of bleeding severity in von Willebrand disease.
    Di Paola J
    Curr Hematol Rep; 2005 Sep; 4(5):345-9. PubMed ID: 16131434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When it comes to von Willebrand disease, does 1 + 1 = 3?
    Montgomery RR
    J Thromb Haemost; 2006 Oct; 4(10):2162-3. PubMed ID: 16889558
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
    Castaman G; Novella E; Castiglia E; Eikenboom JC; Rodeghiero F
    Thromb Res; 2002 Jan; 105(2):135-8. PubMed ID: 11958803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets.
    Cooney KA; Ginsburg D
    Blood; 1996 Mar; 87(6):2322-8. PubMed ID: 8630394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.
    James PD; Notley C; Hegadorn C; Leggo J; Tuttle A; Tinlin S; Brown C; Andrews C; Labelle A; Chirinian Y; O'Brien L; Othman M; Rivard G; Rapson D; Hough C; Lillicrap D
    Blood; 2007 Jan; 109(1):145-54. PubMed ID: 17190853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene conversions are a common cause of von Willebrand disease.
    Gupta PK; Adamtziki E; Budde U; Jaiprakash M; Kumar H; Harbeck-Seu A; Kannan M; Oyen F; Obser T; Wedekind I; Saxena R; Schneppenheim R
    Br J Haematol; 2005 Sep; 130(5):752-8. PubMed ID: 16115133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease.
    O'Brien LA; James PD; Othman M; Berber E; Cameron C; Notley CR; Hegadorn CA; Sutherland JJ; Hough C; Rivard GE; O'Shaunessey D; Lillicrap D;
    Blood; 2003 Jul; 102(2):549-57. PubMed ID: 12649144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.